Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma

Ryoji Kitamura, Takeshi Toyoshima, Hideaki Tanaka, Shintaro Kawano, Takahiro Kiyosue, Ryota Matsubara, Yuichi Goto, Mitsuhiro Hirano, Kazunari Oobu, Seiji Nakamura

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Purpose: The aim of this study was to confirm the expression profile of cytokeratin (CK)17 in comparison with that of CK13 in oral squamous cell carcinoma (OSCC) and leukoplakia and to clarify an association of CK17 with the OSCC differentiation. Materials: The expression of CK17 and CK13 was immunohistochemically examined in 105 patients with OSCC and 108 patients with leukoplakia. A correlation of CK expression with clinicopathological variables was carried out. The over-expression levels of CK17 mRNA were analyzed by real-time RT-PCR in 5 OSCC cell lines (HSC-2, HSC-3, SAS, SQUU-A, SQUU-B). Results: CK17 and CK13 were detected in 101 (96.2 %) and three (2.9 %) of the 105 OSCCs, respectively. CK17 was significantly expressed in well-differentiated OSCC compared to moderately/poorly differentiated OSCC (p < 0.01). As detected in 19 of the 34 dysplastic leukoplakias (55.9 %) and 36 of the 74 hyperplastic leukoplakias (48.6 %), CK17 was significantly expressed in dysplastic leukoplakias (p < 0.01). As detected in 11 of the 34 dysplastic (32.4 %) and 52 of the 74 hyperplastic leukoplakias (70.3 %), CK13 was significantly expressed in hyperplastic leukoplakias (p < 0.01). The relative expression of CK17 mRNA in HSC-2 was significantly higher than in HSC-3 and SAS (p < 0.05). Moreover, the relative expression of CK17 mRNA in SQUU-A was significantly higher than in SQUU-B (p < 0.05). Conclusion: CK17 expression could be associated with the differentiation and the malignancy of OSCC. A combination pattern of CK17/CK13 might be a suitable marker of malignant transformation.

Original languageEnglish
Pages (from-to)1299-1310
Number of pages12
JournalJournal of Cancer Research and Clinical Oncology
Volume138
Issue number8
DOIs
Publication statusPublished - Aug 1 2012

Fingerprint

Keratin-17
Leukoplakia
Squamous Cell Carcinoma
Messenger RNA
Keratins
Real-Time Polymerase Chain Reaction
Cell Differentiation
Cell Line

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma. / Kitamura, Ryoji; Toyoshima, Takeshi; Tanaka, Hideaki; Kawano, Shintaro; Kiyosue, Takahiro; Matsubara, Ryota; Goto, Yuichi; Hirano, Mitsuhiro; Oobu, Kazunari; Nakamura, Seiji.

In: Journal of Cancer Research and Clinical Oncology, Vol. 138, No. 8, 01.08.2012, p. 1299-1310.

Research output: Contribution to journalArticle

Kitamura, Ryoji ; Toyoshima, Takeshi ; Tanaka, Hideaki ; Kawano, Shintaro ; Kiyosue, Takahiro ; Matsubara, Ryota ; Goto, Yuichi ; Hirano, Mitsuhiro ; Oobu, Kazunari ; Nakamura, Seiji. / Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma. In: Journal of Cancer Research and Clinical Oncology. 2012 ; Vol. 138, No. 8. pp. 1299-1310.
@article{e3cc2eb362b643fc8b95c48a88104839,
title = "Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma",
abstract = "Purpose: The aim of this study was to confirm the expression profile of cytokeratin (CK)17 in comparison with that of CK13 in oral squamous cell carcinoma (OSCC) and leukoplakia and to clarify an association of CK17 with the OSCC differentiation. Materials: The expression of CK17 and CK13 was immunohistochemically examined in 105 patients with OSCC and 108 patients with leukoplakia. A correlation of CK expression with clinicopathological variables was carried out. The over-expression levels of CK17 mRNA were analyzed by real-time RT-PCR in 5 OSCC cell lines (HSC-2, HSC-3, SAS, SQUU-A, SQUU-B). Results: CK17 and CK13 were detected in 101 (96.2 {\%}) and three (2.9 {\%}) of the 105 OSCCs, respectively. CK17 was significantly expressed in well-differentiated OSCC compared to moderately/poorly differentiated OSCC (p < 0.01). As detected in 19 of the 34 dysplastic leukoplakias (55.9 {\%}) and 36 of the 74 hyperplastic leukoplakias (48.6 {\%}), CK17 was significantly expressed in dysplastic leukoplakias (p < 0.01). As detected in 11 of the 34 dysplastic (32.4 {\%}) and 52 of the 74 hyperplastic leukoplakias (70.3 {\%}), CK13 was significantly expressed in hyperplastic leukoplakias (p < 0.01). The relative expression of CK17 mRNA in HSC-2 was significantly higher than in HSC-3 and SAS (p < 0.05). Moreover, the relative expression of CK17 mRNA in SQUU-A was significantly higher than in SQUU-B (p < 0.05). Conclusion: CK17 expression could be associated with the differentiation and the malignancy of OSCC. A combination pattern of CK17/CK13 might be a suitable marker of malignant transformation.",
author = "Ryoji Kitamura and Takeshi Toyoshima and Hideaki Tanaka and Shintaro Kawano and Takahiro Kiyosue and Ryota Matsubara and Yuichi Goto and Mitsuhiro Hirano and Kazunari Oobu and Seiji Nakamura",
year = "2012",
month = "8",
day = "1",
doi = "10.1007/s00432-012-1202-6",
language = "English",
volume = "138",
pages = "1299--1310",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Association of cytokeratin 17 expression with differentiation in oral squamous cell carcinoma

AU - Kitamura, Ryoji

AU - Toyoshima, Takeshi

AU - Tanaka, Hideaki

AU - Kawano, Shintaro

AU - Kiyosue, Takahiro

AU - Matsubara, Ryota

AU - Goto, Yuichi

AU - Hirano, Mitsuhiro

AU - Oobu, Kazunari

AU - Nakamura, Seiji

PY - 2012/8/1

Y1 - 2012/8/1

N2 - Purpose: The aim of this study was to confirm the expression profile of cytokeratin (CK)17 in comparison with that of CK13 in oral squamous cell carcinoma (OSCC) and leukoplakia and to clarify an association of CK17 with the OSCC differentiation. Materials: The expression of CK17 and CK13 was immunohistochemically examined in 105 patients with OSCC and 108 patients with leukoplakia. A correlation of CK expression with clinicopathological variables was carried out. The over-expression levels of CK17 mRNA were analyzed by real-time RT-PCR in 5 OSCC cell lines (HSC-2, HSC-3, SAS, SQUU-A, SQUU-B). Results: CK17 and CK13 were detected in 101 (96.2 %) and three (2.9 %) of the 105 OSCCs, respectively. CK17 was significantly expressed in well-differentiated OSCC compared to moderately/poorly differentiated OSCC (p < 0.01). As detected in 19 of the 34 dysplastic leukoplakias (55.9 %) and 36 of the 74 hyperplastic leukoplakias (48.6 %), CK17 was significantly expressed in dysplastic leukoplakias (p < 0.01). As detected in 11 of the 34 dysplastic (32.4 %) and 52 of the 74 hyperplastic leukoplakias (70.3 %), CK13 was significantly expressed in hyperplastic leukoplakias (p < 0.01). The relative expression of CK17 mRNA in HSC-2 was significantly higher than in HSC-3 and SAS (p < 0.05). Moreover, the relative expression of CK17 mRNA in SQUU-A was significantly higher than in SQUU-B (p < 0.05). Conclusion: CK17 expression could be associated with the differentiation and the malignancy of OSCC. A combination pattern of CK17/CK13 might be a suitable marker of malignant transformation.

AB - Purpose: The aim of this study was to confirm the expression profile of cytokeratin (CK)17 in comparison with that of CK13 in oral squamous cell carcinoma (OSCC) and leukoplakia and to clarify an association of CK17 with the OSCC differentiation. Materials: The expression of CK17 and CK13 was immunohistochemically examined in 105 patients with OSCC and 108 patients with leukoplakia. A correlation of CK expression with clinicopathological variables was carried out. The over-expression levels of CK17 mRNA were analyzed by real-time RT-PCR in 5 OSCC cell lines (HSC-2, HSC-3, SAS, SQUU-A, SQUU-B). Results: CK17 and CK13 were detected in 101 (96.2 %) and three (2.9 %) of the 105 OSCCs, respectively. CK17 was significantly expressed in well-differentiated OSCC compared to moderately/poorly differentiated OSCC (p < 0.01). As detected in 19 of the 34 dysplastic leukoplakias (55.9 %) and 36 of the 74 hyperplastic leukoplakias (48.6 %), CK17 was significantly expressed in dysplastic leukoplakias (p < 0.01). As detected in 11 of the 34 dysplastic (32.4 %) and 52 of the 74 hyperplastic leukoplakias (70.3 %), CK13 was significantly expressed in hyperplastic leukoplakias (p < 0.01). The relative expression of CK17 mRNA in HSC-2 was significantly higher than in HSC-3 and SAS (p < 0.05). Moreover, the relative expression of CK17 mRNA in SQUU-A was significantly higher than in SQUU-B (p < 0.05). Conclusion: CK17 expression could be associated with the differentiation and the malignancy of OSCC. A combination pattern of CK17/CK13 might be a suitable marker of malignant transformation.

UR - http://www.scopus.com/inward/record.url?scp=84864361933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864361933&partnerID=8YFLogxK

U2 - 10.1007/s00432-012-1202-6

DO - 10.1007/s00432-012-1202-6

M3 - Article

C2 - 22466643

AN - SCOPUS:84864361933

VL - 138

SP - 1299

EP - 1310

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 8

ER -